Consumers Drive Holistic Wellness Focus in Pharma Media Planning

VML, part of WPP, has released its Future 100: 2026 report identifying shifting consumer health behaviours that will influence pharma media strategy. The report suggests consumers increasingly view holistic wellness, authentic social connections, and personal growth as central to health, alongside greater integration of technology and environmental resilience in care. 

For pharmaceutical marketers and healthcare agencies, this means acknowledging that traditional boundaries between physical, mental, and social health are eroding. The report points to accelerating demand for campaigns and HCP engagement that address mental wellbeing, community-building, and the broader concept of ‘joyspans’ – encompassing quality of life and longevity for both humans and pets. 

On the digital front, VML notes consumers’ evolving relationship with technology in health management, ranging from AI-enabled personalised care platforms to solutions that account for environmental challenges. For pharmaceutical media planners, this raises the stakes for integrating digital channels, data-driven personalisation, and responsive content that reflects real-world concerns such as climate resilience. 

The trend towards prioritising social health also highlights a shift in how channels and messaging are used. Campaigns targeting both DTC and HCP audiences must now consider social and mental health as key drivers; — not only adherence and treatment compliance, but also broader engagement metrics. Agencies and publishers may need to adapt content strategies and measurement frameworks to capture these new priorities.  

While the report does not provide specific data, it offers several directional insights, including the expectation that pharmaceutical advertisers will need to move beyond traditional messaging to address the growing importance of authenticity, resilience, and community. This aligns with industry trends towards omnichannel engagement, where integrated communication and programmatic targeting can address diverse wellness priorities. 

For commercial operations and procurement teams, these shifts amplify the challenge of aligning paid media, content partnerships, and med comms within regulatory frameworks, especially as social and mental health themes gain prominence.

If consumers now expect healthcare content to support both physical longevity and emotional wellbeing, then marketers, publishers, and technology partners will need to adapt both strategy and measurement to remain relevant through 2026 and beyond. 

solli’s Final Thoughts 

This report reinforces the widening scope of pharma media, moving beyond clinical outcomes to encompass social, mental, and environmental wellbeing. Marketers and agencies should monitor rising consumer expectations for authenticity and holistic health in both content and engagement channels.

As omnichannel strategies evolve, integrating social and emotional dimensions will become a cornerstone, not a niche. Pharma media teams who embrace these shifts will be better positioned to connect with audiences, drive meaningful engagement, and withstand changing industry dynamics.